APHERESIS PROCEDURES. Worldwide implemented nowadays. Most of Asian Countries also involved. The usage of this procedure varies between countries.

Size: px
Start display at page:

Download "APHERESIS PROCEDURES. Worldwide implemented nowadays. Most of Asian Countries also involved. The usage of this procedure varies between countries."

Transcription

1

2 ASIA COUNTRIES AS

3 APHERESIS PROCEDURES Worldwide implemented nowadays. Most of Asian Countries also involved. The usage of this procedure varies between countries.

4 SPECTRUM OF APHERESIS Therapeutic Apheresis TPE Leukocytapheresis Thrombocytapheresis Erythrocytapheresis RBC exchange LDL apheresis Adsorptive cytapheresis Lymphocytapheresis ECP Rheopheresis Component Donation Platelet Red cell Plasma Specific Procedure PBSC Collection

5 WHAT TYPE APHERESIS RESEARCH NEED IN ASIA? Basic research Clinical research Translational research

6 WHAT APHERESIS RESEARCH NEED IN ASIA DEPEND ON? Its position in the local healthcare Blood donation use. Trends of diseases. Special medical treatments.

7 Its position in the healthcare Apheresis is still a new/ young science in Asian countries. Should be introduced intensely to medical group (doctor, nurse, student, policy maker). Research in these fields are needed: - Education for physicians, nurses, medical students. - management of apheresis service for hospital and blood center.

8 Blood donation use Apheresis is a new procedure for donors. Most donations were plateletapheresis in Indonesia and surrounding Asian countries. Donation of plasma, redcell, granulocyte, and multicomponents are rare.

9 Blood donation use Research in these fields are needed: - Education for apheresis donor. - Short and longterm side effects to the apheresis donor.

10 TRENDS OF DISEASES Dengue infection is familiar in Asian area, so the platelet apheresis become important TA may be carried out for broad spectrum of disease which comprise endocrinology, hematology, nephrology, neurology, oncology, and rheumatology

11 TRENDS OF DISEASES Research in these fields are needed: - Comparation between single and random donor platelet. - HLA/ HPA

12 TRENDS OF DISEASES Research in these fields are needed: - Platelet bio-properties from apheresis product and its influence in patients - TA modalities - Inline plasma processing

13 SPECIAL MEDICAL TREATMENTS Some countries in Asia have already performed special procedures, but some others have not. Japan: Treatment of Refractory Chron s Disease by Intensive Granulocyte and Monocyte Adsorption Apheresis. Kato et al. Intern Med.2011

14 SPECIAL MEDICAL TREATMENTS South Korea: Safety and efficacy of G-CSF mobilization and collection of autologous peripheral blood stem cells in children with cerebral palsy. Moon et al. Transfusion and Apheresis Science.2013

15 SPECIAL MEDICAL TREATMENTS China: Treatment of patients with polycythemia using ECP reduces RBC count, hemoglobin, and hematocrit. The advantages associated with ECP over conventional therapy should be considered when choosing a treatment plan for patients with polycytemia Liu et al. Transfusion and Apheresis Science.2013

16 SPECIAL MEDICAL TREATMENTS Thailand: Stochastic cellular automata model and Monte Carlo simulations of CD4+ T cell dynamics with a proposed alternative leukapheresis treatment for HIV/ AIDS. Precharattana et al. Computers in Biology and Medicine. 2011

17 SPECIAL MEDICAL TREATMENTS Turkey: Complications of therapeutic apheresis in children. Kara et al. Transfusion and Apheresis Science. 2013

18 SPECIAL MEDICAL TREATMENTS Taiwan: successful largevolume leukapheresis for hematopoietic stem cell collection in a very-lowweight brain tumor infant with coagulopathy. Liao et al. SciVerse ScienceDirect.2013

19 SPECIAL MEDICAL TREATMENTS Research in these fields are needed: - PBSC collections: procedure, the rationale use for revascularization in diabetes cardiac patients - Stem cell transplantation. - GMA

20 SUMMARY Apheresis is still a new procedure for donors, doctors, and patients. The usage of this procedure varies between countries in Asia. Apheresis research need includes procedures, clinical applications and education.

21 Thank you

Hind Al Humaidan, MD, FRCPA Consultant Hematopathologist Director, Blood Bank (DS & TS) / Stem Cell Cord Blood Bank Department of Pathology and

Hind Al Humaidan, MD, FRCPA Consultant Hematopathologist Director, Blood Bank (DS & TS) / Stem Cell Cord Blood Bank Department of Pathology and Guidelines on the Use of Therapeutic Apheresis in Clinical Practice Evidence Based Approach from the Writing Committee of the American Society for Apheresis: The 7th Special Issue Hind Al Humaidan, MD,

More information

GUIDELINES FOR THE TRANSFUSION OF BLOOD COMPONENTS

GUIDELINES FOR THE TRANSFUSION OF BLOOD COMPONENTS CHILDREN S HOSPITALS AND CLINICS OF MINNESOTA Introduction: GUIDELINES FOR THE TRANSFUSION OF BLOOD COMPONENTS These guidelines have been developed in conjunction with the hospital Transfusion Committee.

More information

Spanish Donor Registry. Follow-Up Data

Spanish Donor Registry. Follow-Up Data Spanish Donor Registry. Follow-Up Data Javier de la Rubia S. de Hematología Hospital La Fe Valencia 16th Haemovigilance Seminar Barcelona, March 2014 WHO declared 2010 in its Guiding principle Nr.10: Hig-quality,

More information

Blood Product Modifications: Leukofiltration, Irradiation and Washing

Blood Product Modifications: Leukofiltration, Irradiation and Washing 1. Leukocyte Reduction Definitions and Standards: o Process also known as leukoreduction, or leukofiltration o Applicable AABB Standards, 25th ed. Leukocyte-reduced RBCs At least 85% of original RBCs

More information

Regulatory Challenges in Apheresis Global Perspectives - Cell Therapy

Regulatory Challenges in Apheresis Global Perspectives - Cell Therapy Regulatory Challenges in Apheresis Global Perspectives - Cell Therapy Joseph (Yossi ) Schwartz, MD, MPH Director, Transfusion Medicine & Cellular Therapy Columbia University Medical Center New York Presbyterian

More information

Leukopak 101: A Brief Review of Apheresis

Leukopak 101: A Brief Review of Apheresis White Paper September 2016 Leukopak 101: A Brief Review of Apheresis Lily C. Trajman, Ph.D. Introduction Apheresis refers to the process by which blood is removed from a patient and separated into its

More information

BMTCN REVIEW COURSE PRE-TRANSPLANT CARE

BMTCN REVIEW COURSE PRE-TRANSPLANT CARE BMTCN REVIEW COURSE PRE-TRANSPLANT CARE Jennifer Shamai MS, RN, AOCNS, BMTCN Professional Practice Leader Department of Clinical Practice And Professional Education Click How to edit the Master Experts

More information

INFORMATION ONLY Changes to Requesting HLA/HPA Selected Apheresis Platelets Customer Letter #

INFORMATION ONLY Changes to Requesting HLA/HPA Selected Apheresis Platelets Customer Letter # INFORMATION ONLY Changes to Requesting HLA/HPA Selected Apheresis Platelets Customer Letter # 2015-21 Head Office / Siège social 2015-08-11 Dear Customer, We are writing to inform you of changes to the

More information

Information contained in this listing is collected and maintained by the American Board of Internal Medicine.

Information contained in this listing is collected and maintained by the American Board of Internal Medicine. 1936-1940 1936 1937 1938 1939 1940 Decade Internal Medicine 27 209 90 227 255 808 1941-1950 1941 1942 1943 1944 1945 1946 1947 1948 1949 1950 Decade Internal Medicine 242 204 342 271 314 473 654 486 335

More information

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells Disclaimer: The content of this Deliverable represents the views of the author only and is his/her sole responsibility; it cannot be considered to reflect the views of the European Commission and/or the

More information

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells Disclaimer: The content of this Deliverable represents the views of the author only and is his/her sole responsibility; it cannot be considered to reflect the views of the European Commission and/or the

More information

Journal of Clinical Apheresis 31: (2016) 2016 Wiley Periodicals, Inc.

Journal of Clinical Apheresis 31: (2016) 2016 Wiley Periodicals, Inc. Journal of Clinical Apheresis 31:149 162 (2016) Guidelines on the Use of Therapeutic Apheresis in Clinical Practice Evidence-Based Approach from the Writing Committee of the American Society for Apheresis:

More information

Apheresis: Clinical Indications

Apheresis: Clinical Indications PART 2 Apheresis: Clinical Indications Clinical Vignettes: Hematology Cardiology/Vascular Neurology Solid Organ Transplantation Anatomy of an ASFA Fact Sheet Hematology 40 yo M presenting to the Emergency

More information

Hematopoietic Growth Factors Colony Stimulating Factors. Erythropoietin (Epoetin alfa). Granulocyte-macrophage colonystimulating factor (G-CSF).

Hematopoietic Growth Factors Colony Stimulating Factors. Erythropoietin (Epoetin alfa). Granulocyte-macrophage colonystimulating factor (G-CSF). Hematopoietic Growth Factors Colony Stimulating Factors. Erythropoietin (Epoetin alfa). Granulocyte colony-stimulating factor(g-csf). Granulocyte-macrophage colonystimulating factor (G-CSF). Interleukin-11

More information

Dr.PSRK.Sastry MD, ECMO

Dr.PSRK.Sastry MD, ECMO Peripheral blood stem cell transplantation (Haematopoietic stem cell transplantation) Dr.PSRK.Sastry MD, ECMO Consultant, Medical Oncology Kokilaben Dhirubhai Ambani Hospital Normal hematopoiesis Historical

More information

A Review of Guidelines and Evidence for the Use of Irradiated Blood Products in Solid Tumor, Chemotherapy Patients. Chris Kim 11/29/12

A Review of Guidelines and Evidence for the Use of Irradiated Blood Products in Solid Tumor, Chemotherapy Patients. Chris Kim 11/29/12 A Review of Guidelines and Evidence for the Use of Irradiated Blood Products in Solid Tumor, Chemotherapy Patients Chris Kim 11/29/12 Background Prevention of TAGVHD Irradiation: induces DNA crosslinks,

More information

Jovona Powelson, B.S. MLT (ASCP) Director of Laboratories

Jovona Powelson, B.S. MLT (ASCP) Director of Laboratories Jovona Powelson, B.S. MLT (ASCP) Director of Laboratories Blood Products From the Donor to You Objectives Deliver a brief virtual tour of a blood center. Describe the number of donors needed to meet the

More information

More Efficient Exchange of Sickle Red Blood Cells can be Achieved by Exchanging the Densest Red Blood Cells

More Efficient Exchange of Sickle Red Blood Cells can be Achieved by Exchanging the Densest Red Blood Cells More Efficient Exchange of Sickle Red Blood Cells can be Achieved by Exchanging the Densest Red Blood Cells Thibodeaux, SR, Jamensky, L, Schell K, Irwin L, O Doherty U Hospital of the University of Pennsylvania

More information

GUIDELINES FOR IRRADIATED BLOOD COMPONENTS

GUIDELINES FOR IRRADIATED BLOOD COMPONENTS GUIDELINES FOR IRRADIATED BLOOD COMPONENTS 1. Policy Statement 2. Definitions 1.1 Blood transfusion services shall have a policy which indicates recipients who are to receive irradiated blood components.

More information

Therapeutic Apheresis. SEABB Courtney Hopkins, D.O. American Red Cross, Southern Region

Therapeutic Apheresis. SEABB Courtney Hopkins, D.O. American Red Cross, Southern Region Therapeutic Apheresis SEABB Courtney Hopkins, D.O. American Red Cross, Southern Region Outline Indication Categories Clinical Indications (I and II) Extracorporeal Photopheresis American Red Cross Therapeutic

More information

Need considerable resources material and human.

Need considerable resources material and human. TRAN VAN BINH INTRODUCTION Hematopoietic Stem cell transplantation: the best way to manage Malignancies and non Malignant blood disorders. Need considerable resources material and human. In developping

More information

Donor work up, follow up and ethical issues

Donor work up, follow up and ethical issues Donor work up, follow up and ethical issues Hans Hägglund MD. PhD. Associate Professor Hematology Center, Karolinska University Hospital, Stockholm, Sweden Outline The donor has been identified as a match

More information

The role of HLA in Allogeneic Hematopoietic Stem Cell Transplantation and Platelet Refractoriness.

The role of HLA in Allogeneic Hematopoietic Stem Cell Transplantation and Platelet Refractoriness. The role of HLA in Allogeneic Hematopoietic Stem Cell Transplantation and Platelet Refractoriness. Robert Liwski, MD, PhD, FRCPC Medical Director HLA Typing Laboratory Department of Pathology Dalhousie

More information

PEDIATRIC TRANSFUSION MEDICINE AS A SUB-SPECIALITY TO TRANSFUSION MEDICINE

PEDIATRIC TRANSFUSION MEDICINE AS A SUB-SPECIALITY TO TRANSFUSION MEDICINE PEDIATRIC TRANSFUSION MEDICINE AS A SUB-SPECIALITY TO TRANSFUSION MEDICINE Prof. Neelam Marwaha MD; FAMS; FISHTM. Head, Dept. of Transfusion Medicine PGIMER Chandigarh Dr. Hari Krishan Dhawan MD. Assistant

More information

PLATELETPHERESIS DONOR REGISTRY FOR INDIA. Prashant Pandey Jaypee Hospital, Noida

PLATELETPHERESIS DONOR REGISTRY FOR INDIA. Prashant Pandey Jaypee Hospital, Noida PLATELETPHERESIS DONOR REGISTRY FOR INDIA Prashant Pandey Jaypee Hospital, Noida SDPC vs. RDPC INDEX Why plateletpheresis(pp) donor registry required in India Global and Indian perspective Jaypee hospital

More information

Therapeutic apheresis (introduction) Orieji Illoh, MD November 21, 2006

Therapeutic apheresis (introduction) Orieji Illoh, MD November 21, 2006 Therapeutic apheresis (introduction) Orieji Illoh, MD November 21, 2006 Apheresis Removal of blood Separation into component parts One component is retained and remainder is returned History First tried

More information

Specific Requirements

Specific Requirements Specific Requirements AIMS Specific requirements your patients have for transfusion and how this is managed Classify which patients require: Irradiated components CMV negative components Washed components

More information

Blood Transfusion Guidelines in Clinical Practice

Blood Transfusion Guidelines in Clinical Practice Blood Transfusion Guidelines in Clinical Practice Salwa Hindawi Director of Blood Transfusion Services Associate Professor in Haematology and Transfusion Medicine King Abdalaziz University, Jeddah Saudi

More information

Rationale for RBC Transfusion in SCD

Rationale for RBC Transfusion in SCD Rationale for RBC Transfusion in SCD Dilution of HgbS-containing RBCs via the addition of HgbA-containing cells from the blood of normal donors Suppression of erythropoietin release caused by the rise

More information

Source of platelet concentrates FACHBEREICH MEDIZIN

Source of platelet concentrates FACHBEREICH MEDIZIN FACHBEREICH MEDIZIN Efficacy and safety of platelet concentrates from platelet apheresis donations or whole blood donations Gregor Bein Institute for Clinical Immunology and Transfusion Medicine Justus-Liebig-University

More information

Disclosures. Relevant Financial Relationship(s): List or Nothing to Disclose. Off Label Usage: List or Nothing to Disclose 12/9/2016

Disclosures. Relevant Financial Relationship(s): List or Nothing to Disclose. Off Label Usage: List or Nothing to Disclose 12/9/2016 Staffing to Workload Joy Gomez December 12, 2016 Disclosures Relevant Financial Relationship(s): List or Nothing to Disclose Off Label Usage: List or Nothing to Disclose 1 Objectives Discuss data driven

More information

The New Approach to Assignment of ASFA Categories Introduction to the Fourth Special Issue: Clinical Applications of Therapeutic Apheresis

The New Approach to Assignment of ASFA Categories Introduction to the Fourth Special Issue: Clinical Applications of Therapeutic Apheresis Journal of Clinical Apheresis 00:000 000 (2007) The New Approach to Assignment of ASFA Categories Introduction to the Fourth Special Issue: Clinical Applications of Therapeutic Apheresis Zbigniew M. Szczepiorkowski,

More information

Bor-Sheng Ko. Hematology Division, Department of Internal Medicine, National Taiwan University Hospital

Bor-Sheng Ko. Hematology Division, Department of Internal Medicine, National Taiwan University Hospital Bor-Sheng Ko Hematology Division, Department of Internal Medicine, National Taiwan University Hospital On behalf of Members of Aplastic Anemia Consensus Meeting Diagnosis and classification: Treatment

More information

Global Perspective on Donor and Recipient Safety: Biovigilance in Hematopoietic Cell Transplantation

Global Perspective on Donor and Recipient Safety: Biovigilance in Hematopoietic Cell Transplantation Global Perspective on Donor and Recipient Safety: Biovigilance in Hematopoietic Cell Transplantation John P. Miller, MDPhD Vice President and Senior Medical Director National Marrow Donor Program / Be

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Note: Page numbers of article titles are in boldface type. A Acute lymphoblastic leukemia, in India, 439 440 pediatric, global approach to, 420 424 core resources in low- and middle-income countries, 423

More information

Dependance on chronic transfusion

Dependance on chronic transfusion Dependance on chronic transfusion Pr Saliou Diop Hematology Blood transfusion Dakar- Sénégal diop@cnts-dakar.sn Introduction Chronic transfusion: Regular use of blood transfusion in patients with chronic

More information

Special Requirements Lab Matters. 18 th May Katy Cowan PBM Practitioner NHSBT

Special Requirements Lab Matters. 18 th May Katy Cowan PBM Practitioner NHSBT Special Requirements Lab Matters. 18 th May 2016 Katy Cowan PBM Practitioner NHSBT Special requirements Frozen components and platelets HEV negative Irradiated CMV negative Frozen components and platelets

More information

Composition of Blood

Composition of Blood Composition of Blood Erythrocytes Disorders of Erythrocytes Hematocrit Leukocytes Disorders of Leukocytes Platelets Hemostasis Disorders of Clotting Blood Types Blood Transfusion Unit 7 Blood Composition

More information

Algorithms to predict CD34+ cell collection with the new generation of cell separator machines

Algorithms to predict CD34+ cell collection with the new generation of cell separator machines Algorithms to predict CD34+ cell collection with the new generation of cell separator machines Dr Kenny Douglas SNBTS Clinical Apheresis Unit Beatson West of Scotland Cancer Centre Glasgow, U.K. Predicting

More information

2015/LSIF/FOR/009 Securing Political and Financial Support for Blood Safety - Philippine Experience

2015/LSIF/FOR/009 Securing Political and Financial Support for Blood Safety - Philippine Experience 2015/LSIF/FOR/009 Securing Political and Financial Support for Blood Safety - Philippine Experience Submitted by: Philippines 2 nd APEC Blood Supply Chain Policy Forum Anaheim, United States 23 October

More information

LifeBridge Health Transfusion Service Sinai Hospital of Baltimore Northwest Hospital Center BQA Transfusion Criteria Version#2 POLICY NO.

LifeBridge Health Transfusion Service Sinai Hospital of Baltimore Northwest Hospital Center BQA Transfusion Criteria Version#2 POLICY NO. LifeBridge Health Transfusion Service Sinai Hospital of Baltimore Northwest Hospital Center BQA 1011.02 Transfusion Criteria Version#2 Department POLICY NO. PAGE NO. Blood Bank Quality Assurance Manual

More information

ALL Blood Transfusion samples must be hand-written in accordance with the Trust's Blood Administration Protocol

ALL Blood Transfusion samples must be hand-written in accordance with the Trust's Blood Administration Protocol Blood Transfusion Routine Investigations ALL Blood Transfusion samples must be hand-written in accordance with the Trust's Blood Administration Protocol Full Group & Screen 2ml EDTA Can be stored at 2-8C

More information

An Approach to the Patient Refractory to Platelets Transfusion. Harold Alvarez, MD

An Approach to the Patient Refractory to Platelets Transfusion. Harold Alvarez, MD Harold Alvarez, MD Objectives Explain the etiology of platelet refractoriness Discuss the different types of platelet refractoriness Describe how platelet refractoriness is diagnosed Discuss different

More information

Epogen / Procrit. Epogen / Procrit (epoetin alfa) Description

Epogen / Procrit. Epogen / Procrit (epoetin alfa) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.10.06 Section: Prescription Drugs Effective Date: April1, 2014 Subject: Epogen / Procrit Page: 1 of 7

More information

WAA/SFH Joint Congress

WAA/SFH Joint Congress WAA/SFH Joint Congress Paris, 27 29 April 2016 Mobilization of HSC: History, evolution & impact Pitié-Sâlpétrière Hospital-Paris- France University Hospital of Paris-VI Nabih AZAR MD Key areas covered

More information

BLOOD TRANSFUSION. Dr Lumka Ntabeni

BLOOD TRANSFUSION. Dr Lumka Ntabeni BLOOD TRANSFUSION Dr Lumka Ntabeni Blood transfusion definition SAFE transfer of BLOOD COMPONENTS from a DONOR to a RECEPIENT CONTENT Brief history of blood transfusion How is safety guaranteed? How do

More information

25/10/2017. Clinical Relevance of the HLA System in Blood Transfusion. Outline of talk. Major Histocompatibility Complex

25/10/2017. Clinical Relevance of the HLA System in Blood Transfusion. Outline of talk. Major Histocompatibility Complex Clinical Relevance of the HLA System in Blood Transfusion Dr Colin J Brown PhD FRCPath. October 2017 Outline of talk HLA genes, structure and function HLA and immune complications of transfusion TA-GVHD

More information

Therapeutic Apheresis in South America

Therapeutic Apheresis in South America Therapeutic Apheresis in South America Alfredo Mendrone Jr, MD, PhD Fundação Pró-Sangue Hemocentro de SP / University of São Paulo São Paulo - Brazil Therapeutic Apheresis in Brazil The beginning... Late

More information

THERAPEUTIC APHERESIS IN AFRICA

THERAPEUTIC APHERESIS IN AFRICA THERAPEUTIC APHERESIS IN AFRICA Dr Fatiu A. Arogundade, MBBS, FMCP, FWACP, ISN Fellow Associate Professor of Medicine, Obafemi Awolowo University, Ile-Ife, Nigeria. Conflict of Interest Co investigator

More information

IMPACT OF A DATA-DRIVEN PREDICTION ALGORITHM FOR BLOOD VOLUME PROCESSING IN PERIPHERAL BLOOD STEM CELL COLLECTION IN UNRELATED (NMDP) HPC DONORS

IMPACT OF A DATA-DRIVEN PREDICTION ALGORITHM FOR BLOOD VOLUME PROCESSING IN PERIPHERAL BLOOD STEM CELL COLLECTION IN UNRELATED (NMDP) HPC DONORS IMPACT OF A DATA-DRIVEN PREDICTION ALGORITHM FOR BLOOD VOLUME PROCESSING IN PERIPHERAL BLOOD STEM CELL COLLECTION IN UNRELATED (NMDP) HPC DONORS Anand Padmanabhan, MD PhD QIA BloodCenter of Wisconsin Milwaukee,

More information

A PRIMER ON APHERESIS MEDICINE

A PRIMER ON APHERESIS MEDICINE A PRIMER ON APHERESIS MEDICINE Nicole Aqui, M.D. Assistant Professor Division of Transfusion Medicine Department of Pathology and Laboratory Medicine University of Pennsylvania What is Apheresis? Apheresis

More information

John Goodwin. H&I Laboratory, National Blood Service, Sheffield. FIMLS, MPhil, DipRCPath. John Goodwin, H&I Department, Sheffield

John Goodwin. H&I Laboratory, National Blood Service, Sheffield. FIMLS, MPhil, DipRCPath. John Goodwin, H&I Department, Sheffield John Goodwin FIMLS, MPhil, DipRCPath H&I Laboratory, National Blood Service, Sheffield Patient categories Definitions and background Algorithm Logistics Statistics Troubleshooting / questions Patients

More information

An Introduction to Bone Marrow Transplant

An Introduction to Bone Marrow Transplant Introduction to Blood Cancers An Introduction to Bone Marrow Transplant Rushang Patel, MD, PhD, FACP Florida Hospital Medical Group S My RBC Plt Gran Polycythemia Vera Essential Thrombocythemia AML, CML,

More information

The Global Picture in Blood Transfusions: A Quick Overview

The Global Picture in Blood Transfusions: A Quick Overview The Global Picture in Blood Transfusions: A Quick Overview Jim MacPherson President & CEO MacPherson Strategies jim@macphersonstrategies.com +1 202 468 6548 24 March 2017 WHO 2016 Of the 113 million blood

More information

Blood Components & Indications for Transfusion. Neda Kalhor

Blood Components & Indications for Transfusion. Neda Kalhor Blood Components & Indications for Transfusion Neda Kalhor Blood products Cellular Components: Red blood cells - Leukocyte-reduced RBCs - Washed RBCs - Irradiated RBCs Platelets - Random-donor platelets

More information

Apheresis: Transfusion Indications. Sasha Wilson: Transfusion Senior Nurse

Apheresis: Transfusion Indications. Sasha Wilson: Transfusion Senior Nurse Apheresis: Transfusion Indications Sasha Wilson: Transfusion Senior Nurse Apheresis: Transfusion Indications Focus of talk will be blood component transfusion in the context of apheresis procedures: Special

More information

OneMatch Stem Cell and Marrow Network. Training Guide

OneMatch Stem Cell and Marrow Network. Training Guide OneMatch Stem Cell and Marrow Network Training Guide What is OneMatch all about? OneMatch is a Canadian Program that matches and coordinates the collection of stem cells from potential donors to help save

More information

Blood Transfusion. What is blood transfusion? What are blood banks? When is a blood transfusion needed? Who can donate blood?

Blood Transfusion. What is blood transfusion? What are blood banks? When is a blood transfusion needed? Who can donate blood? What is blood transfusion? A blood transfusion is a safe, common procedure in which blood is given through an intravenous (IV) line in one of the blood vessels. A blood transfusion usually takes two to

More information

#2 - Hematology I Blood Typing

#2 - Hematology I Blood Typing #2 - Blood Typing Objectives: Learn the theory behind blood typing Be able to perform simulated blood typing and analysis Understand the theory behind blood transfusions (donors and recipients) Observe

More information

JOURNAL CLUB INDICATIONS FOR AND ADVERSE EFFECTS OF RED CELL TRANSFUSION. Maggie Woods PGY-3

JOURNAL CLUB INDICATIONS FOR AND ADVERSE EFFECTS OF RED CELL TRANSFUSION. Maggie Woods PGY-3 JOURNAL CLUB INDICATIONS FOR AND ADVERSE EFFECTS OF RED CELL TRANSFUSION Maggie Woods PGY-3 BACKGROUND Objective: To describe evidence for current guidelines, review trends, examine the risks of transfusion

More information

There is no substitute for blood. An introduction to what makes this precious human resource unique.

There is no substitute for blood. An introduction to what makes this precious human resource unique. There is no substitute for blood. An introduction to what makes this precious human resource unique. Blood can t be made in a laboratory. Only the human body can produce this life-saving fluid. Donate

More information

STEM CELL TRANSPLANT IN PEDIATRICS. Erin Meyer, DO, MPH Medical Director, Apheresis Nationwide Children s Hospital Columbus, OH 5/6/17

STEM CELL TRANSPLANT IN PEDIATRICS. Erin Meyer, DO, MPH Medical Director, Apheresis Nationwide Children s Hospital Columbus, OH 5/6/17 STEM CELL TRANSPLANT IN PEDIATRICS Erin Meyer, DO, MPH Medical Director, Apheresis Nationwide Children s Hospital Columbus, OH 5/6/17 Disclosures Nothing to Disclose Overview Stem Cell Transplant History

More information

Clinical Applications: Donor and Cellular Therapy. Jay S. Raval, MD University of North Carolina Chapel Hill, NC

Clinical Applications: Donor and Cellular Therapy. Jay S. Raval, MD University of North Carolina Chapel Hill, NC Clinical Applications: Donor and Cellular Therapy Jay S. Raval, MD University of North Carolina Chapel Hill, NC None Conflicts of Interest Objectives Donor Collections of Red Blood Cells (RBCs), Plasma,

More information

Myeloproliferative Disorders - D Savage - 9 Jan 2002

Myeloproliferative Disorders - D Savage - 9 Jan 2002 Disease Usual phenotype acute leukemia precursor chronic leukemia low grade lymphoma myeloma differentiated Total WBC > 60 leukemoid reaction acute leukemia Blast Pro Myel Meta Band Seg Lymph 0 0 0 2

More information

Special Requirements Lab Matters. 21 st June Barrie Ferguson

Special Requirements Lab Matters. 21 st June Barrie Ferguson Special Requirements Lab Matters. 21 st June 2017 Barrie Ferguson Special requirements Patients requiring Methylene Blue or Solvent Detergent treated Fresh Frozen Plasma Patients requiring apheresis platelets

More information

APHERESIS. Policy Number: OTH027 Effective Date: March 1, 2018

APHERESIS. Policy Number: OTH027 Effective Date: March 1, 2018 APHERESIS UnitedHealthcare Commercial Medical Policy Policy Number: OTH027 Effective Date: March 1, 2018 Table of Contents Page INSTRUCTIONS FOR USE... 1 BENEFIT CONSIDERATIONS... 1 COVERAGE RATIONALE...

More information

Guidelines for Gamma Irradiation of Blood Components

Guidelines for Gamma Irradiation of Blood Components AUSTRALIAN & NEW ZEALAND SOCIETY OF BLOOD TRANSFUSION INC. AUSTRALIAN RED CROSS BLOOD SERVICE NEW ZEALAND BLOOD SERVICE Guidelines for Gamma Irradiation of Blood Components Revised 2003 AN ZS B T Australian

More information

The Burden of Heart Failure in the Asia Pacific. Eugenio B. Reyes, M.D. Associate Professor, University of the Philippines, College of Medicine

The Burden of Heart Failure in the Asia Pacific. Eugenio B. Reyes, M.D. Associate Professor, University of the Philippines, College of Medicine The Burden of Heart Failure in the Asia Pacific Eugenio B. Reyes, M.D. Associate Professor, University of the Philippines, College of Medicine Q1. The most prevalent risk factor for heart failure in the

More information

For peripheral blood stem cell (PBSC) mobilization prior to and during leukapheresis in cancer patients preparing to undergo bone marrow ablation

For peripheral blood stem cell (PBSC) mobilization prior to and during leukapheresis in cancer patients preparing to undergo bone marrow ablation Last Review: 4/2010 NON-FORMULARY Clinical Guideline Neupogen (filgrastim; G-CSF), Neulasta (peg-filgrastim; G-CSF), Neumega (oprelvekin; rh-il-11), Leukine (sargramostim; GM-CSF) Indications Neupogen

More information

Production of the Formed Elements (Chapter 11) *

Production of the Formed Elements (Chapter 11) * OpenStax-CNX module: m62120 1 Production of the Formed Elements (Chapter 11) * Ildar Yakhin Based on Production of the Formed Elements by OpenStax This work is produced by OpenStax-CNX and licensed under

More information

Gene Therapy for Sickle Cell Disease: A Safety/Efficacy Trial

Gene Therapy for Sickle Cell Disease: A Safety/Efficacy Trial Gene Therapy for Sickle Cell Disease: A Safety/Efficacy Trial Elizabeth Hexner A. Introduction Sickle cell disease (SCD) is an autosomal recessive disease of red blood cells (RBCs). A single amino acid

More information

Open Access Full-text Databases in Asia

Open Access Full-text Databases in Asia 4th Asian science editors' conference and workshop Open Access Full-text Databases in Asia July 7, 2017 Tae-sul Seo KISTI Agenda What is an OA Journal? Overview of Open Access in Asia OA Full-Text Journal

More information

UKGS TRANSFUSION SERVICE PRODUCTS AND AVAILABILITY

UKGS TRANSFUSION SERVICE PRODUCTS AND AVAILABILITY Lexington, KY Page 1 of 13 Affected Sites: Enterprise Chandler X Good Samaritan I. PRINCIPLE: The UK Good Samaritan Hospital is dedicated to serve the patients with safe, high quality blood products and

More information

Therapeutic Apheresis Services Annual Review 2016/17

Therapeutic Apheresis Services Annual Review 2016/17 Therapeutic Apheresis Services Annual Review 2016/17 NHS Blood and Transplant (NHSBT) is a major provider of Therapeutic Apheresis Services (TAS) in the NHS. Services are provided across England. Collection

More information

The Vows of Ten Million People The Guardians of the World

The Vows of Ten Million People The Guardians of the World Hope for 10 Million Lives The Vows of Ten Million People The Guardians of the World Speech by Dr. Jeffrey Chell Edited by Su Chi Long Translated by Kelvin Chen Dr. Chell s speech Bone Marrow registrations

More information

Guide to the preparation, use and quality assurance of blood components

Guide to the preparation, use and quality assurance of blood components Contents Foreword...3 Members of the European Committee (Partial Agreement) on Blood Transfusion... 8 Members of the GTS working group... 22 Members of the TS066 working group... 30 Recommendation No.

More information

Journal of Clinical Apheresis 31: (2016) 2016 Wiley Periodicals, Inc.

Journal of Clinical Apheresis 31: (2016) 2016 Wiley Periodicals, Inc. Journal of Clinical Apheresis 31:149 162 (2016) Guidelines on the Use of Therapeutic Apheresis in Clinical Practice Evidence-Based Approach from the Writing Committee of the American Society for Apheresis:

More information

New Zealand Bone Marrow Donor Registry

New Zealand Bone Marrow Donor Registry Title: SECTION 4.0 NZBMDR STANDARDS DONOR RECRUITMENT, ENROLMENT & INFORMATION Authorised by: Executive Officer Contributing Authors: ABMDR Dr Hilary Blacklock Raewyn Fisher NZBMDR-Guidelines-004-13 Date

More information

Case-Control Study: ABO-Incompatible Plasma Causing Hepatic Veno-Occlusive Disease in HSCT

Case-Control Study: ABO-Incompatible Plasma Causing Hepatic Veno-Occlusive Disease in HSCT Case-Control Study: ABO-Incompatible Plasma Causing Hepatic Veno-Occlusive Disease in HSCT Erin Meyer, DO, MPH Assistant Medical Director of Blood, Tissue, and Apheresis Services Children s Healthcare

More information

WELCOME. Evaluation Summary

WELCOME. Evaluation Summary WELCOME Evaluation Summary 489 delegates from 40 countries Delegate s specialty 239 respondents Delegate s professional activity 208 respondents Overall Evaluation This symposium was helpful for your clinical

More information

ADULT TRANSFUSION GUIDELINES ORDERED COMPONENT

ADULT TRANSFUSION GUIDELINES ORDERED COMPONENT ADULT TRANSFUSIN GUIDELINES RDERED Packed red cells (RBCs) RBCs, WBCs, platelets & plasma (minimal) Increase red cell mass and oxygen carrying capacity; generally indicated when Hgb is 7 gm or Hct 21 unless

More information

Transfusion support for the oncology patient

Transfusion support for the oncology patient PART III Oncology CHAPTER 50 Transfusion support for the oncology patient Wade L. Schulz & Edward L. Snyder Department of Laboratory Medicine, Yale School of Medicine, Yale University; and Blood Bank,

More information

Peripheral blood stem cell mobilization and apheresis: analysis of adverse events in 94 normal donors

Peripheral blood stem cell mobilization and apheresis: analysis of adverse events in 94 normal donors Bone Marrow Transplantation, (1999) 24, 1065 1071 1999 Stockton Press All rights reserved 0268 3369/99 $15.00 http://www.stockton-press.co.uk/bmt Peripheral blood stem cell mobilization and apheresis:

More information

Back to the Future: The Resurgence of Bone Marrow??

Back to the Future: The Resurgence of Bone Marrow?? Back to the Future: The Resurgence of Bone Marrow?? Thomas Spitzer, MD Director. Bone Marrow Transplant Program Massachusetts General Hospital Professor of Medicine, Harvard Medical School Bone Marrow

More information

Erythropoiesis Stimulating Agents (ESA)

Erythropoiesis Stimulating Agents (ESA) Erythropoiesis Stimulating Agents (ESA) Policy Number: Original Effective Date: MM.04.008 04/15/2007 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 06/01/2015 Section: Prescription

More information

Clinical Relevance of the HLA System in Blood Transfusion. Dr Colin J Brown PhD FRCPath. October 2017

Clinical Relevance of the HLA System in Blood Transfusion. Dr Colin J Brown PhD FRCPath. October 2017 Clinical Relevance of the HLA System in Blood Transfusion Dr Colin J Brown PhD FRCPath. October 2017 Outline of talk HLA genes, structure and function HLA and immune complications of transfusion TA-GVHD

More information

Blood and Marrow Transplant (BMT) for Sickle Cell Disease

Blood and Marrow Transplant (BMT) for Sickle Cell Disease Blood and Marrow Transplant (BMT) for Sickle Cell Disease Rhiannon is now cured of sickle cell disease after BMT. Blood and marrow transplant (BMT) is a proven cure for sickle cell disease. This handbook

More information

Research Protocol for REAP Bipolar Disorder (REAP-BD)

Research Protocol for REAP Bipolar Disorder (REAP-BD) Research Protocol for REAP Bipolar Disorder (REAP-BD) Summary REAP-BD survey will focus on the prescription patterns on bipolar disorder. Both inpatients and outpatients with bipolar disorder will be enrolled.

More information

Policy for the use of Irradiated blood products

Policy for the use of Irradiated blood products Policy for the use of Irradiated blood products SharePoint Location General Policies and Guidelines SharePoint Index Directory Haematology and Blood Transfusion Sub Area - Key words (for search purposes)

More information

Bloodborne Pathogen CEU Training Course $ HOUR RUSH ORDER PROCESSING FEE ADDITIONAL $50.00

Bloodborne Pathogen CEU Training Course $ HOUR RUSH ORDER PROCESSING FEE ADDITIONAL $50.00 Registration form Bloodborne Pathogen CEU Training Course $100.00 48 HOUR RUSH ORDER PROCESSING FEE ADDITIONAL $50.00 Start and finish dates: You will have 90 days from this date in order to complete this

More information

Implementation of Hematology- Oncology Education Program. Amir Steinberg, MD Samuel Oschin Comprehensive Cancer Center Cedars-Sinai Medical Center

Implementation of Hematology- Oncology Education Program. Amir Steinberg, MD Samuel Oschin Comprehensive Cancer Center Cedars-Sinai Medical Center Implementation of Hematology- Oncology Education Program Amir Steinberg, MD Samuel Oschin Comprehensive Cancer Center Cedars-Sinai Medical Center Cedars-Sinai Medical Center Large, tertiary care center

More information

CURRENT COURSE OFFERINGS

CURRENT COURSE OFFERINGS The American Red Cross offers regular educational opportunities as a convenient way for healthcare providers to receive relevant blood banking and transfusion medicine information. The bi-monthly sessions,

More information

Leukine. Leukine (sargramostim) Description

Leukine. Leukine (sargramostim) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Leukine Page: 1 of 6 Last Review Date: November 30, 2018 Leukine Description Leukine (sargramostim)

More information

Department of Pharmacy, Georgia Health Sciences University, Augusta, GA, USA 3

Department of Pharmacy, Georgia Health Sciences University, Augusta, GA, USA 3 Oncology Volume 2012, Article ID 931071, 5 pages doi:10.1155/2012/931071 Research Article Plerixafor Salvage Is Safe and Effective in Hard-to-Mobilize Patients Undergoing Chemotherapy and Filgrastim-Based

More information

APHERESIS. Guideline Number: MMG003.G Effective Date: January 1, 2018

APHERESIS. Guideline Number: MMG003.G Effective Date: January 1, 2018 APHERESIS UnitedHealthcare of California (HMO) UnitedHealthcare Benefits Plan of California (IEX EPO, IEX PPO) UnitedHealthcare of Oklahoma, Inc. UnitedHealthcare of Oregon, Inc. UnitedHealthcare Benefits

More information

I-1 TIME SERIES - MOST RECENT FIVE YEARS Field of post-m.d. training and source of funding

I-1 TIME SERIES - MOST RECENT FIVE YEARS Field of post-m.d. training and source of funding Family Medicine Emergency Medicine (CFPC) Care of the Elderly (CFPC) Enhanced Skills: Fam. Med. Training FAMILY MEDICINE SUBTOTAL Anesthesiology Critical Care (Anes.) Pain Medicine (Anes.) Public Health

More information

One Day BMT Course by Thai Society of Hematology. Management of Graft Failure and Relapsed Diseases

One Day BMT Course by Thai Society of Hematology. Management of Graft Failure and Relapsed Diseases One Day BMT Course by Thai Society of Hematology Management of Graft Failure and Relapsed Diseases Piya Rujkijyanont, MD Division of Hematology-Oncology Department of Pediatrics Phramongkutklao Hospital

More information

Wiley s Medical and Nursing Journals Collection

Wiley s Medical and Nursing Journals Collection Convenient, cost-effective access to more than 180 journals from one of the world's leading sources of medical and nursing research. The healthcare community often turns to Wiley for up-to-the-minute coverage

More information

Risk of ID transmission. Patient Blood Management - Blood Safety and Component Utilization. Transfusion and Cancer 4/9/2014

Risk of ID transmission. Patient Blood Management - Blood Safety and Component Utilization. Transfusion and Cancer 4/9/2014 Patient Blood Management - Blood Safety and Component Utilization Lowell Tilzer M.D. Pathology and Lab Medicine Kansas University Med Center Risk of ID transmission Pre NAT Post NAT HIV 1:607,000 ~1:2.5

More information